@quirky.quiz: Do You Really Know These Words? Think you’ve got a sharp vocabulary? 🤔 Take this quick-fire quiz and see if you can outsmart the dictionary! 📚💡 Most people get stuck halfway… will you? #VocabularyQuiz #WordChallenge #BrainTeaser #QuizTime #SmartCheck #WordGame #MindTest #LanguageChallenge #IQTestFun #LearnWithFun #TikTokQuiz #TestYourBrain #DailyQuiz #WordPower #ChallengeYourMind

QuirkyQuiz
QuirkyQuiz
Open In TikTok:
Region: US
Friday 15 August 2025 11:30:00 GMT
70623
2086
39
451

Music

Download

Comments

giugal01
crew: 2wheels4nations :
got it all right first time i"m italian and these are mostly latin words easy for me to understand !
2025-11-07 23:12:58
3
casper_ny57
casper :
I got them all right the second time around 😂
2025-08-21 07:48:04
5
daintylion
Dainty Blue :
I choose the exact opposite for each one.😳
2025-09-06 07:24:33
3
valglider
user3086466822961 :
Love these so much thank you! So fun!💖😎
2025-09-02 05:29:15
2
bazinga7267
Bazinga :
jeez...English is hard
2025-08-15 13:26:25
3
fejj_xxv
🩷 The Jeff-inator 🏳️‍🌈 :
these are too easy.
2025-10-12 03:01:40
0
jj397728
JJ :
all of them!
2025-08-15 15:25:26
4
traveithrufood
niki :
Now give us some challenging words
2025-08-15 13:23:21
3
mariarolon143
Maria Rolon143 :
Too easy
2025-10-12 13:04:54
0
kenneth.marsh26
Kenneth Marsh :
Got all of them
2025-08-19 07:46:36
2
pat52190
pat5219 :
I only missed one😁
2025-10-11 23:41:33
0
juicy_fruit586
Juicy_fruit :
This wasn't hard if you read fairly regularly.
2025-10-11 22:27:14
0
mistymountain52
Misty Mountain58 :
Wow unbelievable I got thew all
2025-08-17 22:56:36
2
josephusosborn
josephusosborn :
a
2025-08-18 02:37:05
1
frontierconcepts
frontierconcepts :
I missed 2
2025-10-12 01:01:25
0
dianabat01
dianabatson2 :
3 lol
2025-08-15 16:27:32
1
josephusosborn
josephusosborn :
a
2025-08-18 02:36:09
1
mickbeck7
mick :
yeah I seen a guy get beat up using these words at a truck stop one day 😂
2025-10-12 12:02:37
0
lilibethworldpeac
Lilibeth Worldpeace :
to hide the truth ,im not playing
2025-10-12 12:44:31
0
12mrjames12
Mr James12 :
The verb usurp was my only incorrect answer. 😁
2026-02-07 00:28:58
0
jay_shmoney242
Ghostt♏️ :
😍😍😍
2025-08-18 19:44:36
2
emmanuelthompson435
Emmanuel Thompson400 :
❤️
2025-08-17 22:40:26
2
1342manning
user9800247020133 :
💪💪💪💪💪💪
2025-08-15 15:42:52
3
mbeman
El Don Carlus :
😂😂😂
2025-08-16 06:05:03
2
dyepvfno5cxa
Valerie Darby jasper :
👍🏽
2025-08-17 13:39:06
1
To see more videos from user @quirky.quiz, please go to the Tikwm homepage.

Other Videos

Are GLP-1 receptor agonists (like semaglutide and tirzepatide) doing more than just driving weight loss and glycemic control? Emerging observational studies and clinical trials suggest they may reduce the incidence of obesity-associated cancers and improve overall survival in active cancer patients! Let's break down the scientific mechanisms: 🩺🫁👇
 
 Hi, I'm Dr. Cleo Riles, Harvard-trained cancer researcher and science communicator. Welcome to Part 1 of my ongoing GLP-1s & Cancer Research Series:
 
 🧬 1. THE METABOLIC & TUMOR INTERSECTION:
 
 13 Obesity-Associated Cancers: Obesity drives chronic low-grade inflammation, hyperinsulinemia, elevated IGF-1 (insulin-like growth factor 1), and altered adipokines (leptin/adiponectin ratio)—all of which promote tumor cell proliferation and angiogenesis.
 
 Direct vs. Indirect Pathways: GLP-1s lower cancer risk indirectly through substantial adiposity loss and improved insulin sensitivity. However, researchers are also investigating direct GLP-1 receptor signalling in immune cells (e.g., NK cell restoration) and tumor microenvironments.
 
 📊 2. WHAT THE EARLY SIGNALS SHOW:
 
 Incidence Reduction: Large retrospective cohort studies show significant risk reductions in colorectal, pancreatic, endometrial, ovarian, and breast cancers compared to traditional anti-diabetic medications like insulin or sulfonylureas.
 
 Active Cancer Outcomes: Emerging studies are evaluating whether GLP-1 use during or after active treatment improves recurrence-free survival (RFS) and treatment response (e.g., reversing chemotherapy resistance driven by metabolic dysfunction).
 
 🔬 3. WHAT TO WATCH FOR IN THIS SERIES:
 Over the next several weeks, I'll be breaking down landmark studies, real-world comparative effectiveness data, and my own upcoming research presentation on GLP-1 use and breast cancer outcomes!
 
 👇 What questions do you have about GLP-1 medications and cancer risks? Leave them below!
 #GLP1 #Oncology #CancerResearch #Ozempic #Wegovy
Are GLP-1 receptor agonists (like semaglutide and tirzepatide) doing more than just driving weight loss and glycemic control? Emerging observational studies and clinical trials suggest they may reduce the incidence of obesity-associated cancers and improve overall survival in active cancer patients! Let's break down the scientific mechanisms: 🩺🫁👇 Hi, I'm Dr. Cleo Riles, Harvard-trained cancer researcher and science communicator. Welcome to Part 1 of my ongoing GLP-1s & Cancer Research Series: 🧬 1. THE METABOLIC & TUMOR INTERSECTION: 13 Obesity-Associated Cancers: Obesity drives chronic low-grade inflammation, hyperinsulinemia, elevated IGF-1 (insulin-like growth factor 1), and altered adipokines (leptin/adiponectin ratio)—all of which promote tumor cell proliferation and angiogenesis. Direct vs. Indirect Pathways: GLP-1s lower cancer risk indirectly through substantial adiposity loss and improved insulin sensitivity. However, researchers are also investigating direct GLP-1 receptor signalling in immune cells (e.g., NK cell restoration) and tumor microenvironments. 📊 2. WHAT THE EARLY SIGNALS SHOW: Incidence Reduction: Large retrospective cohort studies show significant risk reductions in colorectal, pancreatic, endometrial, ovarian, and breast cancers compared to traditional anti-diabetic medications like insulin or sulfonylureas. Active Cancer Outcomes: Emerging studies are evaluating whether GLP-1 use during or after active treatment improves recurrence-free survival (RFS) and treatment response (e.g., reversing chemotherapy resistance driven by metabolic dysfunction). 🔬 3. WHAT TO WATCH FOR IN THIS SERIES: Over the next several weeks, I'll be breaking down landmark studies, real-world comparative effectiveness data, and my own upcoming research presentation on GLP-1 use and breast cancer outcomes! 👇 What questions do you have about GLP-1 medications and cancer risks? Leave them below! #GLP1 #Oncology #CancerResearch #Ozempic #Wegovy

About